Valeant Pharmaceuticals International Inc. VRX shares dropped 1.8% to $229.04, on reports it was approaching Zoetis for a potential buyout. Share volume was 101,000, compared to an all-day average of 264,000
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
